The most common side effects of NUCALA include: headache, injection site reactions (pain, redness, swelling, itching, or a ...

Strict control of comorbidities in patients with chronic obstructive pulmonary disease decreases exacerbations, morbimortality, and avoids readmissions. An increasing number of women have the disease, ...

GSK’s Nucala receives positive CHMP opinion for treatment of chronic obstructive pulmonary disease: London, UK Monday, December 15, 2025, 16:00 Hrs [IST] GSK plc announced that ...

A study of nearly 900 adults indicates that although smoking is still the main risk factor for lung function loss, systemic inflammation and obesity also increase the risk of developing chronic ...

The Global Initiative for Chronic Obstructive Lung Disease (GOLD) congratulates UN Member States for recognizing that chronic obstructive pulmonary disease(COPD) is a major cause of disability and ...

Chronic obstructive pulmonary disease (COPD) is a progressive respiratory disorder characterised by persistent airflow limitation and chronic inflammation. Beyond its primary pulmonary manifestations, ...

This combined model achieved a high level of accuracy, suggesting that imaging data alongside basic clinical information could be effective for screening.

Using coronary artery calcium scores alongside cardiovascular risk scores better identifies patients with chronic obstructive ...

Includes Asthma in its strategic plans and Strengthens its Team in 2024-2025Toronto, Ontario--(Newsfile Corp. - December 18, 2025) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX0) ("Therma ...